A significant release of catecholamines within the heart has been observed during myocardial ischemia. Because this can be markedly inhibited by amine-uptake-blocking agents, it has been suggested that its mechanism is a carrier-mediated efflux from neurons, which is not operative under normal conditions. The present work examined this release process in chromaffin cells isolated from the bovine adrenal medulla, a model system for studying the is inhibited by uptake1 blockers such as desipramine, nisoxetine, and (+)-oxaprotiline. These findings have suggested that prolonged ischemia results in an increase in the concentration of intraneuronal cytosolic norepinephrine (by release from vesicles), accompanied by a consequential carrier-mediated efflux from neurons in response to an increase in cytosolic Na+, by reversal of the uptake1 mechanism.5 It is, of course, impossible to make direct observations on cardiac nerve terminals, and so we sought an isolated cell model in which to obtain measurements of the metabolic changes involved. We decided to use isolated adrenal medullary chromaffin cells, which show similarities to sympathetic neurons. Furthermore, it is of interest that hypoxic conditions induce a massive nonneurogenic release of catecholamines from fetal adrenals during parturition,6 possibly by a similar mechanism.
My yocardial ischemia is associated with a progressive release of norepinephrine from adrenergic nerve terminals within the myocardium. This may be of fundamental importance in arrhythmogenesis, since both surgical cardiac denervation and chemical sympathectomy markedly limit arrhythmia occurrence during ischemia and reperfusion.1 Ischemia-induced catecholamine overflow has previously been examined in detail in the isolated perfused rat heart.2-4 During the first 10 minutes of ischemia, electrical stimulation of cardiac sympathetic nerves releases norepinephrine, with the released norepinephrine being rapidly removed from the extracellular space (uptake1). By 20 minutes, however, there is no release in response to sympathetic stimulation,2 although by this time a significant spontaneous overflow is observed. This overflow appears to be nonexocytotic in origin: it occurs under calcium-free conditions and is unaffected by agents that inhibit presynaptic modulation4 but, in contrast, is inhibited by uptake1 blockers such as desipramine, nisoxetine, and (+)-oxaprotiline. These findings have suggested that prolonged ischemia results in an increase in the concentration of intraneuronal cytosolic norepinephrine (by release from vesicles), accompanied by a consequential carrier-mediated efflux from neurons in response to an increase in cytosolic Na+, by reversal of the uptake1 mechanism. 5 It is, of course, impossible to make direct observations on cardiac nerve terminals, and so we sought an isolated cell model in which to obtain measurements of the metabolic changes involved. We decided to use isolated adrenal medullary chromaffin cells, which show similarities to sympathetic neurons. Furthermore, it is of interest that hypoxic conditions induce a massive nonneurogenic release of catecholamines from fetal adrenals during parturition,6 possibly by a similar mechanism.
Materials and Methods

Materials
Isolation of bovine adrenal chromaffin cells. Chromaffin cells were isolated from bovine adrenal glands by a modification of the method of Knight and Baker.7 The adrenal medulla was digested by succes-minutes. The medulla was dissected out, minced, and further digested with 0.1% (wt/vol) collagenase (type I, Sigma Chemical). The resulting cell suspension was washed and filtered several times, and crude cells were purified by centrifugation on a self-generating Percoll gradient.8 The final chromaffin cell fraction was washed with Dulbecco's modified Eagle's medium (DMEM) several times before plating. Cells were plated at a density of 0.5 x 106 cells/ml in 24-well tissue culture plates (1 ml/well) in plating medium composed of 50% DMEM and 50% Ham's F-12 nutrient mix with 5 mM HEPES and 2.4 g/l NaHCO3 (pH 7.4 at 37°C and 5% C02). This was supplemented with 4% (vol/vol) fetal calf serum, 10 IU/ml penicillin, 10 ,g/ml streptomycin, 10 ,g/ml gentamicin, 25 ,ug/ml fluorodeoxyuridine, and 0.25 ,ug/ml amphotericin B. Just before use, 3 ,ug/mI arabinosylcytosine and 50 gg/ml ascorbate (pH 7.4) were added to the medium. Cell cultures were maintained at 37°C in a humidified atmosphere containing 5% CO2 for up to 7 days.
Preparation of soluble proteins of chromaffin granules. Chromaffin granules, the secretory granules of adrenomedullary chromaffin cells, were prepared from freshly dissected bovine adrenal medullae by differential centrifugation and pelleting through 1.6 M sucrose.9 Soluble proteins were released by lysis in 10 mM HEPES followed by centrifugation. Rabbit antiserum against chromogranin A, the major soluble granule protein, was as described.10 Chromogranin A was assumed to comprise 50% of the total soluble protein ( Figure 4) (Po2<20 mm Hg) was induced using a nitrogenflushed chamber and a cell medium of glucose-free Locke's solution that had been deoxygenated and then regassed with nitrogen. 2) Total anoxia was simulated using metabolic inhibition, induced by using 1 mM sodium cyanide and 1 mM iodoacetate in Locke's solution in a normal atmosphere. 3) An alternative model of metabolic inhibition was investigated using 1 ,uM antimycin A and 6 mM 2-deoxy-D-glucose.
Lactate dehydrogenase assay. Lactate dehydrogenase was measured by monitoring the formation of NADH from NAD at 340 nm. 12 Detection ofchromaffin granuleproteins bypolyacrylamide gel electrophoresis and Westem blotting. Proteins were separated on 10% acrylamide gels in the presence of sodium dodecyl sulfate. 13 The discontinuous buffer system of Laemmli14 was used. The protein content of a lysate of chromaffin granules was determined using a dye binding assay.15 Samples were then diluted to give a protein content of 0.05-0.4 ,ug (roughly equivalent to that predicted to be present in samples from the cell supernatants). After separation on polyacrylamide gels, proteins were electrophoretically transferred to nitrocellulose for decoration with antibodies. That the transfer was complete was checked by staining the gel. Blots were visualized by autoradiography after sequential incubations with first antibody, then with anti-rabbit immunoglobulin G-biotin (second antibody), and finally with [`1I]-streptavidin. Autoradiographs were scanned, and peak areas were integrated using a scanning densitometer tojgive numerical values for band intensity.
Gel electrophoresis of cell supematants. Chromaffin cells were treated with Locke's solution (control) or with Locke's solution containing either 10 ,uM nicotine or metabolic inhibitors (as listed above) for 10 minutes. The cell supernatants were removed and microfuged for 2 minutes to remove any cell debris. Samples were diluted 3:1 in sample buffer plus 0.001% (wt/vol) bromophenol blue and 10 ,M dithiothreitol for electrophoresis. Diluted granule lysate was treated in the same way to provide standards when measuring band intensities.
Determination of cytosolic free Ca2 . Cells were plated at a density of 1x 106 cells/ml in 5 -ml Petri dishes. After 2-3 days in culture, the medium was removed and replaced with 5 ml DMEM plus 1% bovine serum albumin at 37°C. The cells were gently scraped off the dish and incubated at room temperature with addition of 2 ,M fura 2-AM (Calbiochem Corp., La Jolla, Calif.) with gentle shaking. After 1 hour, the cells were washed twice with Ca`4-free (Figure 1, left panel) . This release was two to three times higher than the basal release in the culture (shown at time zero), and there was relatively little reaccumulation of the catecholamine over at least 2 hours. Release of catecholamines of roughly similar magnitude and time scale was observed under all three conditions described above; consequently, subsequent experiments were carried out using metabolic inhibition with 1 mM sodium cyanide and 1 mM iodoacetate (method 2 above). Catecholamine release in response to metabolic inhibition is delayed (Figure 1, right panel) . This is in contrast to release induced by nicotine, which is immediate and is virtually complete within 2 minutes.
Carrier-mediated efflux of norepinephrine from ischemic rat hearts has been characterized by its occurrence in the absence of extracellular calcium and by its sensitivity to the uptake, inhibitor, desipramine. 3 Therefore, chromaffin cells were treated for 10 minutes with metabolic inhibitors in the presence or absence of extracellular Ca2' or in the presence of the Ca24 channel blocker, verapamil (Figure 2 ). Catecholamine release induced by metabolic inhibitors was independent of Ca2' and unaffected by verapamil; this is in contrast to catecholamine release evoked by nicotinic agonists, which has an absolute requirement for entry of external Ca24 (Figure 2 ).18
The second feature of carrier-mediated efflux, its sensitivity to uptake blockade, was also examined. Cells were preincubated for 15 minutes with 100 nM Figure 4 ) and by assuming that chromogranin A comprised 50% of the total protein measured. Results of this experiment are presented in Table 1 and Figure 5 .
Chromogranin A secreted from cells stimulated either by nicotine or by metabolic inhibition was significantly more concentrated in the culture medium than under basal conditions (p<0.001), but there was no significant difference between the catecholamine/chromogranin A ratio in the supernatants from the two sets of stimulated cells (or from the unstimulated controls). We conclude that treatment with metabolic inhibitors stimulates release by exocytosis.
This was confirmed by measuring neuropeptide Y, which is also sequestered within the secretory granules, by radioimmunoassay (results not shown). Release of neuropeptide Y paralleled catecholamine release after treatment of the cells both with 10 ,uM nicotine and with metabolic inhibitors.
Release of Cytosolic Components
We investigated lactate dehydrogenase release to confirm that the cells maintained their integrity under conditions of metabolic inhibition. There was no release of lactate dehydrogenase above basal levels during nicotine stimulation or metabolic inhibition ( Figure 6) ; therefore, catecholamine release could not be ascribed to cell lysis. If catecholamine release during metabolic inhibition was caused by a rise in cytosolic catecholamine followed by carrier-mediated efflux, it should be possible to observe an increase in catecholamine release in the presence of 10 gM digitonin (which renders the plasma membrane leaky but does not affect the membranes of chromaffin granules). This treatment (10 minutes) caused release of 18% of the cellular lactate dehydrogenase from control cells ( Figure 6 ) but only 0.9% of the cellular catecholamine, confirming that chromaffin granules remained intact during plasma membrane permeabilization, as found by previous workers.2t Pretreatment of the cells with metabolic inhibitors for 10 minutes failed to increase the proportion of catecholamine released by the digitonin treatment. We conclude that elevation of the cytosolic catecholamine concentration is not significant under these conditions. Measurement of Cytosolic Ca2' (Figure 1 ). This may result from a requirement for initial depletion of energy stores, or other prerequisite metabolic changes may be occurring. Nicotine-evoked catecholamine release from chromaffin cells is strictly calcium dependent; in contrast, anoxia-induced release was not inhibited in calciumfree medium, nor was it blocked by verapamil. In the perfused rat heart, cyanide intoxication releases 40% more norepinephrine in the absence of calcium,5 and this has been ascribed to increased Na+ influx facilitating the carrier-mediated release. Ca2+-free medium only increased catecholamine release from inhibited cells in our experiments by an insignificant amount (9.0+0.4% total release in the absence of Ca21 compared with 8.1+0.3% total release in its presence, p> 1.0).
Although the lack of Ca2' dependence suggests a release mechanism that differs from that involved in nicotine stimulation, the lack of inhibition by desipramine and by (+)-oxaprotiline suggests that metabolic inhibitors do not 
